ENSG Stock Analysis — The Ensign Group
Sector: Healthcare
AI Verdict
ENSG trades at a fair price for its growth, and if its scale and local network moat hold, the numbers suggest you’re not overpaying for the story.
Competitive Moat
The Ensign Group operates skilled nursing and rehabilitation facilities, benefiting from scale-driven efficiencies and deep regulatory expertise that make it hard for smaller operators to compete. Its local cluster strategy creates referral networks and keeps occupancy rates high, reinforcing its competitive position.
Summary
Earnings are expected to jump 26.2% next year while the stock trades at a 21.3x forward P/E.
Where It Stands
ENSG is priced at 21.3x next year's earnings, just below the healthcare sector median of 22x, with analyst consensus calling for 26.2% forward EPS growth and a trailing P/E of 26.9x.
Key Metrics
- Trailing P/E: 26.9x
- Forward P/E: 21.3x
- PEG Ratio: 1.03
- Earnings Growth: +0.3%
- Revenue Growth: +0.2%
- Dividend Yield: 0.00%
- 52-Week High: $218.00
- 52-Week Low: $134.79
Analyst Consensus
9 Buy · 2 Hold · 0 Sell (11 analysts)
Bull Case
You’re paying 21.3x forward earnings for 26.2% expected EPS growth, which is cheap for the growth on offer if Ensign’s cluster strategy keeps driving occupancy and margins.
Bear Case
If the P/E multiple drops from 21.3x to the sector median of 18x, that would cut about 15% off the share price even if growth comes through.
Catalyst to Watch
Watch quarterly occupancy rates and regulatory changes—either could shift earnings expectations and justify or challenge the current multiple.